[LGND] YoY Annual Result on 31-Dec-2010 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
03-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#FY]
Profit Trend
YoY- -542.45%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 48,974 31,388 30,037 23,538 38,940 27,315 12,894 24.88%
PBT 9,207 -3,865 -2,930 -15,403 -9,872 -97,515 -53,456 -
Tax 374 -1,191 -13,103 -2,617 -7,924 -55 -18,697 -
NP 11,421 -527 10,176 -12,515 -1,948 -98,114 281,688 -41.35%
Tax Rate -4.06% - - - - - - -
Total Cost 37,553 31,915 19,861 36,053 40,888 125,429 -268,794 -
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 23.32 -1.68 33.88 -53.17 -5.00 -359.19 2,184.64 -53.04%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
EPS 0.56 -0.03 0.52 -0.64 -0.10 -6.16 17.22 -43.47%
EPS Diluted 0.55 -0.03 0.52 -0.64 -0.10 -6.16 17.22 -43.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.